Results 11 to 20 of about 5,957,667 (290)
Sphingolipids in thyroid eye disease [PDF]
Frontiers in Endocrinology, 2023 Graves’ disease (GD) is caused by an autoimmune formation of autoantibodies and autoreactive T-cells against the thyroid stimulating hormone receptor (TSHR).
Anne Gulbins +3 more
doaj +4 more sources
Life, 2022 Thyroid eye disease (TED), an autoimmune inflammatory disorder of the orbit, presents with a potential array of clinical sequelae. The pathophysiology behind TED has been partially characterized in the literature.
Ramy Rashad +4 more
doaj +5 more sources
Graves’ ophthalmopathy – thyroid eye disease [PDF]
Journal of Education, Health and Sport, 2019 Graves’ disease (GD) is an autoimmune disorder that affects thyroid. It is caused by antibody, named thyroid-stimulating immunoglobulin (TIS) that acts like thyroid stimulating hormone (TSH), resulting in thyroid hormone overproduction – condition called
Dagna Siedlecka +3 more
doaj +7 more sources
Editorial: Thyroid eye disease [PDF]
Frontiers in OphthalmologyAlon Kahana +6 more
doaj +5 more sources
QJM, 2015 A 72-year-old man presented to the emergency with dizziness and progressive double vision for one month. He was diagnosed as Graves’ disease at another medical center at his age of 60, and he had received antithyroid medication with restoration of euthyroidism. There had been no ocular abnormality until 6 years ago, when proptosis occurred. In addition,
H-J, Hsu, C-K, Hsu, T-S, Chen, C-H, Hsu
openaire +3 more sources
Epidemiology of Thyroid Eye Disease
, 2022 A detailed understanding of the epidemiology of thyroid eye disease allows clinicians to identify and treat patients who may be at higher risk for the disease. The following manuscripts provide a detailed understanding of the epidemiology of thyroid eye disease as well as risk factors for complications of more severe disease.
Bartley G. B. +34 more
openaire +2 more sources
This open access book provides a comprehensive, open access reference on thyroid eye disease for healthcare professionals. It is structured for easy reference around the key topics in thyroid eye disease management, with sections on natural history and pathogenesis, diagnosis and investigation, medical management, surgical management and psychological ...
Shah SS, Stokkermans TJ, Patel BC.
europepmc +4 more sources
BMJ, 2009 Thyroid eye disease is a relatively rare condition, with an incidence of 2.9 to 16.0 cases per 100 000 population per year.1 The disease mainly affects women. Many patients experience distressing symptoms, and a few develop sight threatening complications. Patients are often young or middle aged and at the peak of their career.
Petros, Perros +2 more
core +5 more sources
Update on thyroid eye disease and management
Clinical Ophthalmology, 2009 Erick D Bothun,1,2 Ryan A Scheurer,1 Andrew R Harrison,1,3 Michael S Lee1,4,51Departments of Ophthalmology, 2Pediatrics, 3Otolaryngology, 4Neurosurgery, and 5Neurology, University of Minnesota, Minneapolis, Minnesota, USAAbstract: Thyroid eye ...
Erick D Bothun +3 more
doaj +1 more source
Ocular Surface Changes in Patients with Thyroid Eye Disease: An Observational Clinical Study
Clinical Ophthalmology, 2021 Ibrahim Y Allam,1 Sihem Lazreg,2 Mohamed Shafik Shaheen,1 Mohamed Fahmy Doheim,1 Mai A Mohammed1 1Ophthalmology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt; 2Cabinet Ophtalmologie, Alger Centre, Algiers ...
Allam IY +4 more
doaj +1 more source